Jeito Capital renewed in “TIBI 2”

Paris, France, September 11th 2023 – Three years after being the 1st biopharma fund to be awarded the Tibi 1 label, Jeito Capital has announced that it has been renewed in the Tibi 2 selection, confirming its role as an accelerator in the financing of technology...